問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberES-CMSC01-B1101
Active

2020-04-01 - 2027-12-31

Phase I

Recruiting1

ICD-10I63.50

Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery

ICD-10I63.511

Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery

ICD-10I63.512

Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery

ICD-10I63.519

Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery

ICD-10I63.521

Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery

ICD-10I63.522

Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery

ICD-10I63.529

Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery

ICD-10I63.531

Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery

ICD-10I63.532

Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery

ICD-10I63.539

Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery

ICD-10I63.541

Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery

ICD-10I63.542

Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery

ICD-10I63.549

Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery

ICD-10I63.59

Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery

ICD-10I63.8

Other cerebral infarction

ICD-10I63.9

Cerebral infarction, unspecified

ICD-9434.91

Unspecified cerebral artery occlusion with cerebral infarction

  • Trial Applicant

    EVER SUPREME BIO TECHNOLOGY CO., LTD.

  • Sponsor

  • Trial scale

    Taiwan Single Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Chon-Haw Tsai Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    10~13 participants

  • Global

    10~13 participants